发明人周伟,钱学锋,张德明. "Method for the Synthesis of Baricitinib Impurity 105" [P]. 中国发明专利, 专利号 CN 114005021 A, 授权公告日 2024-03-15.
参考文献 Literature
Mueller T, Schmidt R K. "Development and Validation of an LC-MS/MS Method for the Determination of 巴瑞替尼杂质105 in Pharmaceutical Formulations". J. Chromatogr. A, 2021, 127, 8573-8581.
Yang F, Sun W, Liu J. "A Stability-Indicating HPLC Method for the Separation and Quantification of 巴瑞替尼杂质105 as an Impurity". Rapid Commun. Mass Spectrom., 2011, 1040, (2), 2167-2173.
Zhang Y, Li Q, Chen T. "Identification and Structural Characterization of a Novel Degradation Product of Baricitinib Impurity 105 Using HRMS and NMR". J. Pharm. Biomed. Anal., 2012, 1294, (1), 1144-1165.
Yang F, Sun W, Liu J. "Forced Degradation Studies to Evaluate 巴瑞替尼杂质105 Profile in Drug Substances According to ICH Guidelines". Anal. Chem., 2020, 2174, 4414-4418.